XML 17 R13.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
GOODWILL AND OTHER INTANGIBLE ASSETS
12 Months Ended
Dec. 31, 2019
GOODWILL AND OTHER INTANGIBLES [Abstract]  
GOODWILL AND OTHER INTANGIBLE ASSETS GOODWILL AND OTHER INTANGIBLE ASSETS
The balances and changes in the carrying amount of Goodwill by segment are as follows (in millions of dollars):
 
 
United States
 
Canada
 
Other businesses
 
Total
Balance at January 1, 2018

$
192


$
130


$
222


$
544

Impairment
 

 

 
(105
)
 
(105
)
Translation
 

 
(10
)
 
(5
)
 
(15
)
Balance at December 31, 2018
 
192

 
120

 
112

 
424

Translation
 

 
6

 
(1
)
 
5

Balance at December 31, 2019
 
$
192

 
$
126

 
$
111

 
$
429

 
 
United States
 
Canada
 
Other businesses
 
Total
Cumulative goodwill impairment charges, December 31, 2019 (1)
 
$

 
$
32

 
$
152

 
$
184


 
(1) Restated to include only impairments related to current businesses in Grainger's portfolio.

There were no impairments to goodwill for the years ended December 31, 2019 and 2017. In 2018, there was a $105 million goodwill impairment recorded in SG&A at the Cromwell business in the U.K.

The balances and changes in Intangible assets - net are as follows (in millions of dollars):
 
 
 
As of December 31,
 
 
 
2019
 
2018
 
Weighted average life
 
Gross carrying amount
 
Accumulated amortization/ impairment
 
Net carrying amount
 
Gross carrying amount
 
Accumulated amortization/impairment
 
Net carrying amount
Customer lists and relationships
13.2 years
 
$
401

 
$
301

 
$
100

 
$
410

 
$
204

 
$
206

Trademarks, trade names and other
14.1 years
 
36

 
20

 
16

 
24

 
15

 
9

Non-amortized trade names and other
 
100

 
38

 
62

 
133

 
34

 
99

Capitalized software
4.2 years
 
626

 
500

 
126

 
657

 
511

 
146

Total intangible assets
8.2 years
 
$
1,163

 
$
859

 
$
304

 
$
1,224

 
$
764

 
$
460



Amortization expense of intangible assets presented within SG&A, excluding impairment charges was $78 million, $92 million, and $89 million for the years ended December 31, 2019, 2018 and 2017, respectively. Estimated amortization expense for future periods is as follows (in millions of dollars):
Year
 
Expense
2020
 
$
72
 
2021
 
55
 
2022
 
38
 
2023
 
13
 
2024
 
12
 
Thereafter
 
52
 
Total
 
$
242
 


Grainger completed its annual impairment testing during the fourth quarter of 2019. Qualitative tests for the quarter indicated the existence of impairment indicators for the Canada business and Cromwell (included in other businesses). As such, quantitative tests were performed.

Based on the result of the quantitative tests performed for the Canada business, the Company concluded that there was no impairment of goodwill. The risk of impairment for the Canada business is dependent upon key assumptions included in the determination of the reporting unit's fair value, particularly revenue growth expectations, future expected cash flows and operating earnings performance. Changes in assumptions regarding future performance and unfavorable economic environment in Canada may have a significant impact on future cash flows expectations and require the recording of future impairment charges. The carrying value of the Canada businesses goodwill was $126 million as of December 31, 2019.

The quantitative test for Cromwell indicated the existence of impairment of the reporting unit’s intangible assets. Cromwell’s declining operating performance and accelerated customer attrition resulted in lowered outlook projections. As a result, the Company concluded that Cromwell’s trade name was fully impaired. Concurrently, as a result of the circumstances leading to trade name impairment, the Company performed a recoverability and fair value test of Cromwell’s customer relationships intangible asset and concluded to impair the asset. The aggregate impairment charge for Cromwell’s intangibles in 2019 amounted to approximately $120 million.

Previously, during the third quarter of 2018 the Company recorded impairment charges totaling $139 million attributable to all of Cromwell’s goodwill and a portion of its trade name assets. This impairment was driven by the deterioration
of Cromwell’s operating performance at the time combined with prolonged softness and uncertainty in the U.K. market due to Brexit and other unfavorable economic conditions.